F&FFinancial Insights

Financial Metrics

MD Pediatrix Medical Group, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 124233000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 147785000.0 +19.0% USD 10-Q 2017-07-28
Quarterly 2016-09-30 156891000.0 +6.2% USD 10-Q 2017-11-01
Quarterly 2017-03-31 106037000.0 -32.4% USD 10-Q 2018-05-04
Quarterly 2017-06-30 121904000.0 +15.0% USD 10-Q 2018-08-02
Quarterly 2017-09-30 126432000.0 +3.7% USD 10-Q 2018-11-01
Quarterly 2018-03-31 99663000.0 -21.2% USD 10-Q 2019-05-02
Quarterly 2018-06-30 122393000.0 +22.8% USD 10-Q 2019-08-01
Quarterly 2018-09-30 104208000.0 -14.9% USD 10-Q 2019-11-01
Quarterly 2019-03-31 78455000.0 -24.7% USD 10-Q 2020-05-07
Quarterly 2019-06-30 59387000.0 -24.3% USD 10-Q 2020-07-30
Quarterly 2019-09-30 48568000.0 -18.2% USD 10-Q 2020-11-06
Quarterly 2020-03-31 10803000.0 -77.8% USD 10-Q 2021-05-07
Quarterly 2020-06-30 34565000.0 +220.0% USD 10-Q 2021-08-06
Quarterly 2020-09-30 20459000.0 -40.8% USD 10-Q 2021-10-28
Quarterly 2021-03-31 26104000.0 +27.6% USD 10-Q 2022-04-28
Quarterly 2021-06-30 50016000.0 +91.6% USD 10-Q 2022-08-04
Quarterly 2021-09-30 58793000.0 +17.5% USD 10-Q 2022-11-03
Quarterly 2022-03-31 39108000.0 -33.5% USD 10-Q 2023-05-02
Quarterly 2022-06-30 50155000.0 +28.2% USD 10-Q 2023-08-03
Quarterly 2022-09-30 47387000.0 -5.5% USD 10-Q 2023-11-02
Quarterly 2023-03-31 30041000.0 -36.6% USD 10-Q 2024-05-07
Quarterly 2023-06-30 48498000.0 +61.4% USD 10-Q 2024-08-06
Quarterly 2023-09-30 40272000.0 -17.0% USD 10-Q 2024-11-01
Quarterly 2024-03-31 15892000.0 -60.5% USD 10-Q 2025-05-06
Quarterly 2024-06-30 -157723000.0 -1092.5% USD 10-Q 2025-08-05
Quarterly 2024-09-30 33827000.0 +121.4% USD 10-Q 2025-11-03
Quarterly 2025-03-31 32101000.0 -5.1% USD 10-Q 2025-05-06
Quarterly 2025-06-30 59867000.0 +86.5% USD 10-Q 2025-08-05
Quarterly 2025-09-30 68051000.0 +13.7% USD 10-Q 2025-11-03
Annual 2016-12-31 571687000.0 USD 10-K 2019-02-14
Annual 2017-12-31 454892000.0 -20.4% USD 10-K 2020-02-20
Annual 2018-12-31 248388000.0 -45.4% USD 10-K 2021-02-18
Annual 2019-12-31 171756000.0 -30.9% USD 10-K 2022-02-17
Annual 2020-12-31 98132000.0 -42.9% USD 10-K 2023-02-17
Annual 2021-12-31 202918000.0 +106.8% USD 10-K 2024-02-20
Annual 2022-12-31 172688000.0 -14.9% USD 10-K 2025-02-20
Annual 2023-12-31 7321000.0 -95.8% USD 10-K 2026-02-19
Annual 2024-12-31 -68713000.0 -1038.6% USD 10-K 2026-02-19
Annual 2025-12-31 208813000.0 +403.9% USD 10-K 2026-02-19

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 67771000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 82325000.0 +21.5% USD 10-Q 2017-07-28
Quarterly 2016-09-30 96421000.0 +17.1% USD 10-Q 2017-11-01
Quarterly 2017-03-31 54691000.0 -43.3% USD 10-Q 2018-05-04
Quarterly 2017-06-30 63698000.0 +16.5% USD 10-Q 2018-08-02
Quarterly 2017-09-30 65880000.0 +3.4% USD 10-Q 2018-11-01
Quarterly 2018-03-31 63428000.0 -3.7% USD 10-Q 2019-11-01
Quarterly 2018-06-30 79412000.0 +25.2% USD 10-Q 2019-11-01
Quarterly 2018-09-30 208415000.0 +162.4% USD 10-Q 2019-11-01
Quarterly 2019-03-31 -242872000.0 -216.5% USD 10-Q 2020-11-06
Quarterly 2019-06-30 -8245000.0 +96.6% USD 10-Q 2020-11-06
Quarterly 2019-09-30 -1507033000.0 -18178.1% USD 10-Q 2020-11-06
Quarterly 2020-03-31 -18712000.0 +98.8% USD 10-Q 2021-10-28
Quarterly 2020-06-30 -672436000.0 -3493.6% USD 10-Q 2021-10-28
Quarterly 2020-09-30 -41044000.0 +93.9% USD 10-Q 2021-10-28
Quarterly 2021-03-31 17642000.0 +143.0% USD 10-Q 2022-11-03
Quarterly 2021-06-30 35011000.0 +98.5% USD 10-Q 2022-11-03
Quarterly 2021-09-30 30788000.0 -12.1% USD 10-Q 2022-11-03
Quarterly 2022-03-31 -21188000.0 -168.8% USD 10-Q 2023-11-02
Quarterly 2022-06-30 27136000.0 +228.1% USD 10-Q 2023-11-02
Quarterly 2022-09-30 30728000.0 +13.2% USD 10-Q 2023-11-02
Quarterly 2023-03-31 14206000.0 -53.8% USD 10-Q 2024-11-01
Quarterly 2023-06-30 28282000.0 +99.1% USD 10-Q 2024-11-01
Quarterly 2023-09-30 21391000.0 -24.4% USD 10-Q 2024-11-01
Quarterly 2024-03-31 4035000.0 -81.1% USD 10-Q 2025-11-03
Quarterly 2024-06-30 -153025000.0 -3892.4% USD 10-Q 2025-11-03
Quarterly 2024-09-30 19441000.0 +112.7% USD 10-Q 2025-11-03
Quarterly 2025-03-31 20737000.0 +6.7% USD 10-Q 2025-11-03
Quarterly 2025-06-30 39260000.0 +89.3% USD 10-Q 2025-11-03
Quarterly 2025-09-30 71708000.0 +82.6% USD 10-Q 2025-11-03
Annual 2016-12-31 324596000.0 USD 10-K 2019-02-14
Annual 2017-12-31 320372000.0 -1.3% USD 10-K 2020-02-20
Annual 2018-12-31 268629000.0 -16.2% USD 10-K 2021-02-18
Annual 2019-12-31 -1497702000.0 -657.5% USD 10-K 2022-02-17
Annual 2020-12-31 -796488000.0 +46.8% USD 10-K 2023-02-17
Annual 2021-12-31 130937000.0 +116.4% USD 10-K 2024-02-20
Annual 2022-12-31 66331000.0 -49.3% USD 10-K 2025-02-20
Annual 2023-12-31 -60408000.0 -191.1% USD 10-K 2026-02-19
Annual 2024-12-31 -99069000.0 -64.0% USD 10-K 2026-02-19
Annual 2025-12-31 165388000.0 +266.9% USD 10-K 2026-02-19

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.74 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 0.89 +20.3% USD/shares 10-Q 2017-07-28
Quarterly 2016-09-30 1.04 +16.9% USD/shares 10-Q 2017-11-01
Quarterly 2017-03-31 0.59 -43.3% USD/shares 10-Q 2018-05-04
Quarterly 2017-06-30 0.69 +16.9% USD/shares 10-Q 2018-08-02
Quarterly 2017-09-30 0.71 +2.9% USD/shares 10-Q 2018-11-01
Quarterly 2018-03-31 0.68 -4.2% USD/shares 10-Q 2019-05-02
Quarterly 2018-06-30 0.85 +25.0% USD/shares 10-Q 2019-08-01
Quarterly 2018-09-30 0.72 -15.3% USD/shares 10-Q 2019-11-01
Quarterly 2019-03-31 -2.82 -491.7% USD/shares 10-Q 2020-05-07
Quarterly 2019-06-30 -0.1 +96.5% USD/shares 10-Q 2020-07-30
Quarterly 2019-09-30 -15.23 -15130.0% USD/shares 10-Q 2020-11-06
Quarterly 2020-03-31 -0.22 +98.6% USD/shares 10-Q 2021-05-07
Quarterly 2020-06-30 -8.06 -3563.6% USD/shares 10-Q 2021-08-06
Quarterly 2020-09-30 -0.49 +93.9% USD/shares 10-Q 2021-10-28
Quarterly 2021-03-31 0.21 +142.9% USD/shares 10-Q 2022-04-28
Quarterly 2021-06-30 0.41 +95.2% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.36 -12.2% USD/shares 10-Q 2022-11-03
Quarterly 2022-03-31 -0.25 -169.4% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 0.32 +228.0% USD/shares 10-Q 2023-08-03
Quarterly 2022-09-30 0.37 +15.6% USD/shares 10-Q 2023-11-02
Quarterly 2023-03-31 0.17 -54.1% USD/shares 10-Q 2024-05-07
Quarterly 2023-06-30 0.34 +100.0% USD/shares 10-Q 2024-08-06
Quarterly 2023-09-30 0.26 -23.5% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 0.05 -80.8% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 -1.84 -3780.0% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.23 +112.5% USD/shares 10-Q 2025-11-03
Quarterly 2025-03-31 0.25 +8.7% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.46 +84.0% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.85 +84.8% USD/shares 10-Q 2025-11-03
Annual 2016-12-31 3.52 USD/shares 10-K 2019-02-14
Annual 2017-12-31 3.47 -1.4% USD/shares 10-K 2020-02-20
Annual 2018-12-31 2.95 -15.0% USD/shares 10-K 2021-02-18
Annual 2019-12-31 -17.94 -708.1% USD/shares 10-K 2022-02-17
Annual 2020-12-31 -9.55 +46.8% USD/shares 10-K 2023-02-17
Annual 2021-12-31 1.54 +116.1% USD/shares 10-K 2024-02-20
Annual 2022-12-31 0.79 -48.7% USD/shares 10-K 2025-02-20
Annual 2023-12-31 -0.73 -192.4% USD/shares 10-K 2026-02-19
Annual 2024-12-31 -1.19 -63.0% USD/shares 10-K 2026-02-19
Annual 2025-12-31 1.97 +265.5% USD/shares 10-K 2026-02-19

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.73 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 0.89 +21.9% USD/shares 10-Q 2017-07-28
Quarterly 2016-09-30 1.04 +16.9% USD/shares 10-Q 2017-11-01
Quarterly 2017-03-31 0.59 -43.3% USD/shares 10-Q 2018-05-04
Quarterly 2017-06-30 0.69 +16.9% USD/shares 10-Q 2018-08-02
Quarterly 2017-09-30 0.71 +2.9% USD/shares 10-Q 2018-11-01
Quarterly 2018-03-31 0.68 -4.2% USD/shares 10-Q 2019-05-02
Quarterly 2018-06-30 0.85 +25.0% USD/shares 10-Q 2019-08-01
Quarterly 2018-09-30 0.72 -15.3% USD/shares 10-Q 2019-11-01
Quarterly 2019-03-31 -2.81 -490.3% USD/shares 10-Q 2020-05-07
Quarterly 2019-06-30 -0.1 +96.4% USD/shares 10-Q 2020-07-30
Quarterly 2019-09-30 -15.15 -15050.0% USD/shares 10-Q 2020-11-06
Quarterly 2020-03-31 -0.22 +98.5% USD/shares 10-Q 2021-05-07
Quarterly 2020-06-30 -8.03 -3550.0% USD/shares 10-Q 2021-08-06
Quarterly 2020-09-30 -0.49 +93.9% USD/shares 10-Q 2021-10-28
Quarterly 2021-03-31 0.21 +142.9% USD/shares 10-Q 2022-04-28
Quarterly 2021-06-30 0.41 +95.2% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.36 -12.2% USD/shares 10-Q 2022-11-03
Quarterly 2022-03-31 -0.25 -169.4% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 0.32 +228.0% USD/shares 10-Q 2023-08-03
Quarterly 2022-09-30 0.37 +15.6% USD/shares 10-Q 2023-11-02
Quarterly 2023-03-31 0.17 -54.1% USD/shares 10-Q 2024-05-07
Quarterly 2023-06-30 0.34 +100.0% USD/shares 10-Q 2024-08-06
Quarterly 2023-09-30 0.26 -23.5% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 0.05 -80.8% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 -1.84 -3780.0% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.23 +112.5% USD/shares 10-Q 2025-11-03
Quarterly 2025-03-31 0.24 +4.3% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.46 +91.7% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.84 +82.6% USD/shares 10-Q 2025-11-03
Annual 2016-12-31 3.49 USD/shares 10-K 2019-02-14
Annual 2017-12-31 3.45 -1.1% USD/shares 10-K 2020-02-20
Annual 2018-12-31 2.93 -15.1% USD/shares 10-K 2021-02-18
Annual 2019-12-31 -17.83 -708.5% USD/shares 10-K 2022-02-17
Annual 2020-12-31 -9.55 +46.4% USD/shares 10-K 2023-02-17
Annual 2021-12-31 1.53 +116.0% USD/shares 10-K 2024-02-20
Annual 2022-12-31 0.79 -48.4% USD/shares 10-K 2025-02-20
Annual 2023-12-31 -0.73 -192.4% USD/shares 10-K 2026-02-19
Annual 2024-12-31 -1.19 -63.0% USD/shares 10-K 2026-02-19
Annual 2025-12-31 1.94 +263.0% USD/shares 10-K 2026-02-19

8-K Material Event Details

44 filings · 85 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

205 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-01 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Other disposed transaction
F
Common Stock 26,931 $19.85 $534,580 149,236
2026-03-01 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Equity grant / award
A
Common Stock 39,925 $0.00 $0 176,167
2025-12-15 ORDAN MARK S Chief Executive Officer Open-market sell
S
Common Stock 23,000 $22.41 $515,430 302,805
2025-11-17 Rucker Michael A. Open-market sell
S
Common Stock 10,478 $23.00 $240,994 59,101
2025-11-06 Linynsky Laura A Open-market sell
S
Common Stock 10,000 $21.65 $216,500 32,232
2025-08-20 McEachin Thomas Equity grant / award
G
Common Stock 625 $0.00 $0 11,427
2025-08-19 McEachin Thomas Equity grant / award
G
Common Stock 54,021 $0.00 $0 12,052
2025-08-01 Neeb Don Gregory EVP, Chief Invest & Strategy Equity grant / award
A · derivative
Performance Share Unit 320,000 $0.00 $0 320,000
2025-08-01 Neeb Don Gregory EVP, Chief Invest & Strategy Equity grant / award
A
Common Stock 81,346 $0.00 $0 81,346
2025-06-10 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Equity grant / award
G
Common Stock 10,371 $0.00 $0 136,242
2025-06-01 Rossi Kasandra H EVP, CFO and Treasurer Other disposed transaction
F
Common Stock 677 $14.15 $9,580 76,976
2025-06-01 Rossi Kasandra H EVP, CFO and Treasurer Equity grant / award
A
Common Stock 26,502 $0.00 $0 77,653
2025-05-23 Weis Shirley A Equity grant / award
G
Common Stock 18,360 $0.00 $0 11,427
2025-05-09 ORDAN MARK S Chief Executive Officer Other disposed transaction
F
Common Stock 7,225 $14.44 $104,329 131,458
2025-05-08 Young Sylvia Jean Equity grant / award
A
Common Stock 11,427 $0.00 $0 40,618
2025-03-06 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Equity grant / award
G
Common Stock 26,497 $0.00 $0 100,338
2025-03-01 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Other disposed transaction
F
Common Stock 8,975 $14.77 $132,561 126,835
2025-02-25 Weis Shirley A Equity grant / award
G
Common Stock 17,668 $0.00 $0 18,360
2025-01-12 ORDAN MARK S Chief Executive Officer Equity grant / award
A · derivative
Performance Share Unit 640,000 $0.00 $0 640,000
2024-12-01 Rossi Kasandra H EVP, CFO and Treasurer Equity grant / award
A
Common Stock 11,112 $0.00 $0 54,869
2024-11-13 ORDAN MARK S Open-market sell
S
Common Stock 27,600 $15.35 $423,660 138,683
2024-11-08 Moore Mary Ann E EVP, GC, Chief Admin Off & Sec Open-market sell
S
Common Stock 8,108 $16.00 $129,728 135,810
2024-08-30 Swift James D Chief Executive Officer Open-market sell
S
Common Stock 11,100 $10.79 $119,769 170,001
2024-08-27 Linynsky Laura A Open-market sell
S
Common Stock 7,000 $11.16 $78,120 30,805
2024-08-12 Richards C Marc EVP, Chief Financial Officer Open-market sell
S
Common Stock 17,438 $10.08 $175,775 175,347
2024-08-09 Richards C Marc EVP, Chief Financial Officer Open-market sell
S
Common Stock 32,562 $10.08 $328,225 192,785
2024-06-01 Swift James D Chief Executive Officer Equity grant / award
A
Common Stock 105,165 $0.00 $0 181,101
2024-05-09 Starcher John M. Jr. Equity grant / award
A
Common Stock 18,360 $0.00 $0 54,637
2024-03-13 Pickert Curtis EVP, Chief Operating Officer Equity grant / award
G
Common Stock 12,923 $0.00 $0 53,001
2024-03-01 Pickert Curtis EVP, Chief Operating Officer Other disposed transaction
F
Common Stock 9,160 $9.15 $83,814 65,924
2023-12-14 Moore Mary Ann E EVP, General Counsel & Sec Open-market sell
S
Common Stock 970 $9.62 $9,331 81,385
2023-12-14 Moore Mary Ann E EVP, General Counsel & Sec Open-market sell
S
Common Stock 1,150 $9.62 $11,063 15,730
2023-06-14 Swift James D Chief Executive Officer Open-market sell
S
Common Stock 13,193 $14.14 $186,549 96,638
2023-06-07 Pickert Curtis EVP, Chief Operating Officer Equity grant / award
G
Common Stock 1,166 $0.00 $0 75,084
2023-06-01 Pickert Curtis EVP, Chief Operating Officer Other disposed transaction
F
Common Stock 376 $13.30 $5,001 76,250
2023-05-25 ORDAN MARK S Dir Open-market sell
S
Common Stock 33,000 $13.26 $437,580 147,923
2023-05-19 Weis Shirley A Dir Open-market sell
S
Common Stock 1,007 $13.63 $13,725 17,668
2023-05-18 Weis Shirley A Dir Open-market sell
S
Common Stock 17,993 $13.55 $243,805 18,675
2023-05-15 Pickert Curtis EVP, Chief Operating Officer Equity grant / award
G
Common Stock 5,984 $0.00 $0 76,626
2023-05-12 Young Sylvia Jean Dir Equity grant / award
A
Common Stock 10,831 $0.00 $0 10,831
2023-05-11 SANSONE GUY P Dir Equity grant / award
A
Common Stock 10,965 $0.00 $0 49,961
2023-03-01 Swift James D Chief Executive Officer Other disposed transaction
F
Common Stock 9,909 $15.74 $155,968 109,831
2023-03-01 Swift James D Chief Executive Officer Equity grant / award
A
Common Stock 49,758 $0.00 $0 119,740
2022-12-31 ORDAN MARK S Chief Executive Officer Other disposed transaction
F
Common Stock 98,932 $14.86 $1,470,130 247,713
2022-11-21 ORDAN MARK S Chief Executive Officer Open-market sell
S
Common Stock 22,166 $15.45 $342,465 346,645
2022-11-07 Swift James D EVP, Chief Operating Officer Open-market sell
S
Common Stock 24,000 $15.31 $367,440 87,956
2022-09-26 Andreano Dominic J EVP, General Counsel and Secy Other disposed transaction
F
Common Stock 4,267 $16.81 $71,728 189,440
2022-05-12 McEachin Thomas Dir Equity grant / award
A
Common Stock 8,480 $0.00 $0 25,321
2022-03-01 Hinson Roger Mack Pres., PDX & OBX Medical Group Other disposed transaction
F
Common Stock 10,244 $23.47 $240,427 109,457
2022-01-11 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 40,107 $26.58 $1,066,044 739,450
2022-01-10 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 59,893 $26.44 $1,583,571 779,557
2022-01-05 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 12,639 $27.42 $346,561 839,450
2022-01-04 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 87,361 $27.43 $2,396,312 852,089
2021-12-31 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 6,564 $27.16 $178,278 939,450
2021-12-30 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 45,397 $27.19 $1,234,344 946,014
2021-12-29 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 25,000 $27.28 $682,000 991,411
2021-12-28 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 44,514 $27.28 $1,214,342 1,016,411
2021-12-27 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 66,868 $27.17 $1,816,804 1,060,925
2021-11-10 Hinson Roger Mack Pres., PDX & OBX Medical Group Open-market sell
S
Common Stock 8,800 $28.38 $249,744 107,391
2021-10-29 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 9,238 $26.87 $248,225 101,666
2021-10-28 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 10,387 $29.00 $301,223 1,127,793
2021-10-04 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 1,270 $29.00 $36,830 1,138,180
2021-09-02 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 10,000 $31.83 $318,300 110,843
2021-08-30 ORDAN MARK S Chief Executive Officer Exercise / conversion
M · derivative
Employee Stock Option (right to buy) 95,000 $17.65 $1,676,750 455,331
2021-08-30 ORDAN MARK S Chief Executive Officer Open-market sell
S
Common Stock 95,000 $35.09 $3,333,550 208,425
2021-08-30 ORDAN MARK S Chief Executive Officer Exercise / conversion
M
Common Stock 95,000 $17.65 $1,676,750 303,425
2021-08-10 Hinson Roger Mack Pres., PDX & OBX Medical Group Open-market sell
S
Common Stock 8,799 $32.35 $284,648 116,129
2021-07-12 MEDEL ROGER MD Dir Other disposed transaction
F
Common Stock 83,092 $29.77 $2,473,649 1,139,450
2021-07-01 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 100,000 $30.31 $3,031,000 1,222,542
2021-06-01 Pepia John C Principal Accounting Officer Other disposed transaction
F
Common Stock 7,858 $31.98 $251,299 120,785
2021-05-12 Weis Shirley A Dir Equity grant / award
A
Common Stock 4,885 $0.00 $0 17,223
2021-04-01 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 782 $25.81 $20,183 1,317,657
2021-04-01 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 99,218 $25.40 $2,520,137 1,318,439
2021-03-01 Pepia John C Principal Accounting Officer Other disposed transaction
F
Common Stock 2,568 $24.43 $62,736 128,573
2021-03-01 Pepia John C Principal Accounting Officer Equity grant / award
A
Common Stock 10,205 $0.00 $0 130,858
2021-03-01 Pepia John C Principal Accounting Officer Equity grant / award
A
Common Stock 10,204 $0.00 $0 120,653
2021-01-04 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 52,961 $23.89 $1,265,238 1,490,232
2021-01-04 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 47,039 $23.41 $1,101,183 1,543,193
2020-12-10 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 33,194 $23.04 $764,919 1,590,232
2020-12-09 MEDEL ROGER MD Dir Open-market sell
S
Common Stock 66,806 $23.00 $1,536,672 1,623,426
2020-09-26 Andreano Dominic J EVP, General Counsel and Secy Equity grant / award
A · derivative
Employee Stock Option (right to buy) 96,000 $0.00 $0 96,000
2020-09-26 Andreano Dominic J EVP, General Counsel and Secy Equity grant / award
A
Common Stock 21,686 $0.00 $0 75,394
2020-09-15 Nikolopoulos Nicholas J EVP Chf Strategy & Growth Offi Open-market sell
S
Common Stock 10,000 $19.02 $190,179 71,954
2020-07-31 FARBER STEPHEN D Former Chief Financial Officer Equity grant / award
G
Common Stock 200,000 $0.00 $0 78,027
2020-07-12 Starcher John M. Jr. Dir Equity grant / award
A
Common Stock 11,331 $0.00 $0 11,947
2020-06-02 FARBER STEPHEN D Chief Financial Officer Equity grant / award
A
Common Stock 200,000 $0.00 $0 429,608
2020-06-01 Pepia John C Principal Accounting Officer Other disposed transaction
F
Common Stock 329 $15.53 $5,109 110,449
2020-03-01 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Restricted Shares Units 7,862 $0.00 $0 0
2020-03-01 Pepia John C Principal Accounting Officer Other disposed transaction
F
Common Stock 3,023 $17.09 $51,663 110,615
2020-03-01 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 7,862 113,638
2020-02-13 Kadre Manuel Dir Equity grant / award
A
Common Stock 4,717 $0.00 $0 124,313
2019-12-01 Andreano Dominic J SVP, General Counsel and Secy Other disposed transaction
F
Common Stock 2,952 $26.12 $77,106 59,365
2019-11-01 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 5,000 $22.88 $114,403 10,821
2019-09-03 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 5,000 $20.81 $104,050 15,821
2019-09-01 FARBER STEPHEN D Chief Financial Officer Other disposed transaction
F
Common Stock 19,675 $21.08 $414,749 149,951
2019-08-12 FERNANDEZ MICHAEL Dir Open-market buy
P
Common Stock 61,204 $21.35 $1,306,816 250,000
2019-08-12 FERNANDEZ MICHAEL Dir Open-market buy
P
Common Stock 61,205 $21.35 $1,306,837 350,288
2019-08-09 FERNANDEZ MICHAEL Dir Open-market buy
P
Common Stock 124,553 $21.52 $2,680,879 188,796
2019-08-08 FERNANDEZ MICHAEL Dir Open-market buy
P
Common Stock 64,243 $21.68 $1,392,596 64,243
2019-08-08 FERNANDEZ MICHAEL Dir Open-market buy
P
Common Stock 64,242 $21.68 $1,392,574 164,530
2019-06-01 Pepia John C Principal Accounting Officer Equity grant / award
A
Common Stock 50,690 $0.00 $0 86,758
2019-03-13 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 3,300 $30.40 $100,331 20,821
2019-03-07 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 4,608 $30.16 $138,984 64,461
2019-03-01 MEDEL ROGER MD Chief Executive Officer Other disposed transaction
F
Common Stock 19,331 $32.91 $636,183 1,558,878
2019-02-28 WALDEMAR, MD CARLO A Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 17,584 $18.91 $332,513 0
2019-02-28 WALDEMAR, MD CARLO A Dir Other disposed transaction
F
Common Stock 10,095 $32.94 $332,529 27,085
2019-02-28 WALDEMAR, MD CARLO A Dir Equity grant / award
A
Common Stock 17,584 $18.91 $332,513 37,180
2019-02-27 SOSA ENRIQUE Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 17,584 $18.91 $332,513 0
2019-02-27 SOSA ENRIQUE Dir Other disposed transaction
F
Common Stock 9,956 $33.40 $332,530 32,633
2019-02-27 SOSA ENRIQUE Dir Equity grant / award
A
Common Stock 17,584 $18.91 $332,513 42,589
2019-02-20 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 1,289 $36.22 $46,690 69,069
2019-02-12 SOSA ENRIQUE Dir Equity grant / award
A
Common Stock 3,699 $0.00 $0 25,005
2019-01-22 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 2,500 $36.60 $91,500 28,583
2018-12-01 Clark David A. Pres. Mednax Natl Med Group Equity grant / award
A
Common Stock 54,000 $0.00 $0 86,845
2018-08-14 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 1,025 $48.20 $49,405 27,583
2018-08-14 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 1,540 $48.18 $74,197 28,608
2018-08-14 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 935 $48.17 $45,039 30,148
2018-06-12 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 6,516 $46.56 $303,374 31,083
2018-06-11 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 18,000 $46.95 $845,059 24,896
2018-06-01 CALABRO JOSEPH M President and COO Open-market sell
S
Common Stock 22,186 $45.20 $1,002,738 332,747
2018-05-24 Andreano Dominic J SVP, General Counsel and Secy Exercise / conversion
M · derivative
Stock Options (Right to Buy) 6,000 $27.71 $166,290 0
2018-05-24 Andreano Dominic J SVP, General Counsel and Secy Other disposed transaction
F
Common Stock 4,143 $46.91 $194,348 42,896
2018-05-24 Andreano Dominic J SVP, General Counsel and Secy Exercise / conversion
M
Common Stock 6,000 $27.71 $166,290 47,039
2018-05-22 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 3,000 $27.71 $83,145 0
2018-05-22 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 3,000 $46.43 $139,290 36,716
2018-05-22 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 3,000 $27.71 $83,145 39,716
2018-05-21 Lopez-Blanco Vivian Chief Financial Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 40,000 $25.14 $1,005,600 0
2018-05-21 Lopez-Blanco Vivian Chief Financial Officer Other disposed transaction
F
Common Stock 26,058 $46.60 $1,214,303 121,927
2018-05-21 Lopez-Blanco Vivian Chief Financial Officer Exercise / conversion
M
Common Stock 40,000 $25.14 $1,005,600 147,985
2018-05-04 ALVAREZ CESAR L Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,668 $27.71 $295,664 0
2018-05-04 ALVAREZ CESAR L Dir Other disposed transaction
F
Common Stock 6,578 $44.95 $295,681 39,987
2018-05-04 ALVAREZ CESAR L Dir Exercise / conversion
M
Common Stock 10,668 $27.71 $295,664 46,565
2018-03-19 SOSA ENRIQUE Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 10,668 $27.71 $295,664 0
2018-03-19 SOSA ENRIQUE Dir Other disposed transaction
F
Common Stock 5,259 $56.23 $295,714 21,306
2018-03-19 SOSA ENRIQUE Dir Exercise / conversion
M
Common Stock 10,668 $27.71 $295,664 26,565
2018-03-13 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 3,000 $27.71 $83,145 3,000
2018-03-13 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 3,000 $58.35 $175,063 36,716
2018-03-13 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 3,000 $27.71 $83,145 39,716
2018-03-01 SOSA ENRIQUE Dir Equity grant / award
A
Common Stock 2,350 $0.00 $0 15,897
2017-12-12 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 3,000 $27.71 $83,145 6,000
2017-12-12 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 3,000 $51.58 $154,740 32,569
2017-12-12 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 3,000 $27.71 $83,145 35,569
2017-12-07 Andreano Dominic J SVP, General Counsel and Secy Equity grant / award
A · derivative
Restricted Shares Units 9,828 $0.00 $0 9,828
2017-11-03 ALVAREZ CESAR L Dir Open-market sell
S
Common Stock 10,668 $42.59 $454,375 33,547
2017-11-01 ALVAREZ CESAR L Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,668 $32.33 $344,843 0
2017-11-01 ALVAREZ CESAR L Dir Exercise / conversion
M
Common Stock 10,668 $32.33 $344,843 44,215
2017-09-12 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 3,000 $27.71 $83,145 9,000
2017-09-12 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 3,000 $42.85 $128,550 32,569
2017-09-12 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 3,000 $27.71 $83,145 35,569
2017-06-14 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 1,969 $57.57 $113,355 18,072
2017-06-01 MEDEL ROGER MD Chief Executive Officer Other disposed transaction
F
Common Stock 38,257 $0.00 $0 1,288,739
2017-06-01 MEDEL ROGER MD Chief Executive Officer Equity grant / award
A
Common Stock 110,532 $0.00 $0 1,343,836
2017-06-01 SOSA ENRIQUE Dir Equity grant / award
A
Common Stock 2,292 $0.00 $0 13,547
2017-05-05 Lopez-Blanco Vivian Chief Financial Officer Open-market sell
S
Common Stock 7,778 $55.82 $434,183 51,319
2017-03-15 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 6,517 $70.84 $461,645 18,229
2017-02-23 SOSA ENRIQUE Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,668 $32.33 $344,843 0
2017-02-23 SOSA ENRIQUE Dir Open-market sell
S
Common Stock 10,668 $69.65 $743,060 11,255
2017-02-23 SOSA ENRIQUE Dir Exercise / conversion
M
Common Stock 10,668 $32.33 $344,843 21,923
2017-02-17 Lopez-Blanco Vivian Chief Financial Officer Open-market sell
S
Common Stock 15,164 $70.01 $1,061,606 59,097
2017-02-16 Pepia John C Principal Accounting Officer Exercise / conversion
M · derivative
Stock Options (Right to Buy) 2,500 $28.55 $71,362 0
2017-02-16 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 1,500 $69.58 $104,372 28,525
2017-02-16 Pepia John C Principal Accounting Officer Open-market sell
S
Common Stock 1,000 $69.58 $69,581 30,025
2017-02-16 Pepia John C Principal Accounting Officer Exercise / conversion
M
Common Stock 2,500 $28.55 $71,362 31,025
2017-02-13 MEDEL ROGER MD Chief Executive Officer Equity grant / award
G
Common Stock 16,020 $0.00 $0 1,233,304
2017-02-10 Goldschmidt, MD Pascal J Dir Other disposed transaction
J
Common Stock 25,294 $67.82 $1,715,318 17,749
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 8,280 $36.25 $300,150 0
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 9,922 $29.36 $291,260 0
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,668 $27.71 $295,664 0
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 818 $32.33 $26,442 0
2017-02-10 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 25,294 $67.82 $1,715,318 17,749
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M
Common Stock 8,280 $36.25 $300,150 43,043
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M
Common Stock 9,922 $29.36 $291,260 34,763
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M
Common Stock 10,668 $27.71 $295,664 24,841
2017-02-10 Goldschmidt, MD Pascal J Dir Exercise / conversion
M
Common Stock 818 $32.33 $26,442 14,173
2017-02-09 WALDEMAR, MD CARLO A Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 5,334 $32.33 $172,422 0
2017-02-09 WALDEMAR, MD CARLO A Dir Open-market sell
S
Common Stock 5,334 $67.90 $362,186 11,255
2017-02-09 WALDEMAR, MD CARLO A Dir Exercise / conversion
M
Common Stock 5,334 $32.33 $172,422 16,589
2017-01-17 Lopez-Blanco Vivian Chief Financial Officer Open-market sell
S
Common Stock 10,000 $70.95 $709,500 74,261
2016-12-07 Goldschmidt, MD Pascal J Dir Open-market buy
P
Common Stock 2,100 $66.52 $139,682 13,355
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 8,280 $36.25 $300,150 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 9,922 $29.36 $291,260 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 17,584 $18.91 $332,513 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 10,668 $27.71 $295,664 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 5,174 $32.33 $167,250 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 26,668 $29.40 $784,039 0
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 8,280 $36.25 $300,150 89,551
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 9,922 $29.36 $291,260 81,271
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 17,584 $18.91 $332,513 71,349
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 10,668 $27.71 $295,664 53,765
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 5,174 $32.33 $167,250 43,097
2016-11-10 Kadre Manuel Dir Exercise / conversion
M
Common Stock 26,668 $29.40 $784,039 37,923
2016-09-14 Goldschmidt, MD Pascal J Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 1,500 $32.33 $48,488 818
2016-09-14 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 156 $65.03 $10,145 11,255
2016-09-14 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 303 $65.02 $19,701 11,411
2016-09-14 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 566 $65.01 $36,796 11,714
2016-09-14 Goldschmidt, MD Pascal J Dir Open-market sell
S
Common Stock 475 $65.00 $30,875 12,280
2016-09-14 Goldschmidt, MD Pascal J Dir Exercise / conversion
M
Common Stock 1,500 $32.33 $48,488 12,755
2016-06-13 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 3,922 $68.80 $269,834 24,746
2016-06-08 WALDEMAR, MD CARLO A Dir Exercise / conversion
M · derivative
Stock Options (Right to Buy) 5,334 $32.33 $172,422 5,334
2016-06-08 WALDEMAR, MD CARLO A Dir Open-market sell
S
Common Stock 5,334 $70.50 $376,047 11,255
2016-06-08 WALDEMAR, MD CARLO A Dir Exercise / conversion
M
Common Stock 5,334 $32.33 $172,422 16,589
2016-06-07 WAGNER KARL B President, Eastern Division Open-market sell
S
Common Stock 27,482 $68.45 $1,881,143 105,932
2016-06-01 Andreano Dominic J SVP, General Counsel and Secy Equity grant / award
A
Common Stock 7,355 $0.00 $0 28,668
2016-05-16 Andreano Dominic J SVP, General Counsel and Secy Open-market sell
S
Common Stock 3,000 $68.53 $205,590 21,313
2016-05-02 Lopez-Blanco Vivian Chief Financial Officer Open-market sell
S
Common Stock 9,350 $71.22 $665,885 64,083

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
13
Material Event Filings (8-K) — 12 months
7

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.